Equillium to Participate in Upcoming Investor Conferences

Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that management will participate in the following upcoming investor conferences:

Cantor Global Healthcare Conference 2026 Format: Fireside Chat & 1x1 Meetings Date: Wednesday, September 9, 2026 Time: 9:45 AM EDT Webcast Link: Here

H.C. Wainwright 28 th Annual Global Investment Conference Format: Company Presentation & 1x1 Meetings Date: Monday, September 14, 2026 Time: 11:00 AM EDT

Members of the Equillium management team will be available to meet with investors who are registered to attend the conference.

A live webcast of the Cantor fireside chat may also be accessed on the Events & Presentations page, located under the Investor Relations section on equilliumbio.com . A replay of the webcast will be available for approximately 45 days following the conference.

About Equillium Equillium is a biotechnology innovator with a mission to develop highly impactful therapies to treat severe autoimmune and inflammatory disorders.

For more information, visit www.equilliumbio.com .

Investor Contact PJ Kelleher LifeSci Advisors, LLC +1-617-430-7579 [email protected]